Overview
- Applied Nutrition said it will introduce new items tailored to people using GLP-1 weight-loss drugs later in 2026.
- The company already sells high-protein ready meals launched in late 2025 for customers on these treatments.
- Chief executive Thomas Ryder said these customers often prefer smaller portions and look for specific supplements.
- For the six months to January 31, pre-tax profit rose 77.1% to £20.9 million as sales climbed 56.5% to £74.5 million.
- Management kept a revenue goal of about £140 million for the year and warned conflict could reduce Middle East sales.